Gregory A. Dekaban0000-0002-3087-4660
Gregory A. Dekaban received his B.S. degree (honors) in 1976 from Queen’s University and his Ph.D. degree in 1981 from the University of Western Ontario, both in biochemistry. He subsequently completed postdoctoral studies at the Frederick Cancer Research and Development Centre, Frederick, Maryland between 1981 and 1984 before taking on a scientist position at Connaught Laboratories Ltd. (now known as Sanofi Pasteur). In 1987, Dr. Dekaban became a Robarts Research Institute Scientist and Immunology Group Codirector and Assistant Professor at the Department of Microbiology and Immunology at the University of Western Ontario in London Ontario, Canada. He progressed through the academic ranks and became a Full Professor in 1998 while remaining as a Robarts Scientist. Dr. Dekaban’s research has focused on the neurovirology and immunology of HIV, HTLV-I, and Herpes Simplex virus I/II. He also had strong interests in vaccine development for HIV, HTLV-I, and cancer. Most recently, he has focused on developing methods to track cells in vivo using cellular magnetic resonance imaging techniques. Dr. Dekaban is currently developing an anti-inflammatory therapy of acute spinal cord injury.
Biography Updated on 13 December 2010